American journal of perinatology · 2008
Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine.
Сравнительное исследованиеСтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Neri Isabella, Monari Francesca, Valensise Herbert, Vasapollo Barbara, Facchinetti Fabio, Volpe Annibale
Аннотация
We compared the effects of ritodrine and atosiban treatments on fetal cardiovascular behavior by computerized nonstress test (c-NST) analysis. Women diagnosed with preterm labor were randomized to receive either atosiban or ritodrine. A c-NST was performed at least 12 hours after the last corticosteroid administration. Differences in fetal cardiovascular behavior were evident when treatment was given before 30 weeks' gestation. Ritodrine induced higher fetal heart rates, lower long-term variation values, and lower low:high-frequency ratios compared with atosiban. Atosiban induced higher gestational ages at delivery and higher birth weights than ritodrine. The mean Apgar scores were similar for atosiban and ritodrine groups at 1 and 5 minutes. No 5-minute Apgar score was < 7. With respect with atosiban, ritodrine treatment induces tachycardia and a lower variability of fetal heart rate. Such changes could be erroneously interpreted as signal of fetal distress, namely at lower gestational age.
Предметные рубрики MeSH
AdultAnalysis of VarianceChi-Square DistributionDiagnosis, Computer-AssistedDose-Response Relationship, DrugDrug Administration ScheduleFemaleFetal MonitoringFollow-Up StudiesGestational AgeHeart Rate, FetalHumansInfant, NewbornInfusions, IntravenousMaternal AgeObstetric Labor, PrematurePregnancyPregnancy OutcomeProbabilityReference ValuesRisk AssessmentRitodrineTocolysisTreatment OutcomeUterine ContractionVasotocinYoung Adult